Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taiji Group Chongqing Pharmaceutical Factory of Chinese Medicine is a leading Chinese pharmaceutical enterprise focused on the modernization and production of Traditional Chinese Medicine (TCM). Established in 1951 and currently operating as a key subsidiary of the Taiji Group (under Sinopharm), the company is famous for its flagship product, Huoxiang Zhengqi Liquid, a staple in Chinese households for gastrointestinal and seasonal ailments. The company maintains extensive GMP-certified manufacturing facilities that produce a variety of dosage forms, including oral liquids, tablets, capsules, and granules. Its research initiatives focus on the standardization of herbal extracts and the clinical validation of traditional formulas for respiratory, digestive, and cardiovascular health. As a major player in the TCM industry, it integrates traditional heritage with modern pharmaceutical technology to serve both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Pharmaceutical Factory of Chinese Medicine.